Cargando…
Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells
BACKGROUND: Bisdemethoxycurcumin (BDMC) is an active component of curcumin and a chemotherapeutic agent, which has been suggested to inhibit tumor growth, invasion and metastasis in multiple cancers. But its contribution and mechanism of action in invasion and metastasis of non-small cell lung cance...
Autores principales: | Xu, Jin-Hong, Yang, He-Ping, Zhou, Xiang-Dong, Wang, Hai-Jing, Gong, Liang, Tang, Chun-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830320/ https://www.ncbi.nlm.nih.gov/pubmed/25963361 http://dx.doi.org/10.4103/0366-6999.156795 |
Ejemplares similares
-
Inhibition of DNA methyltransferase 1 by RNA interference reverses epithelial-mesenchymal transition in highly metastatic 95D lung cancer cells by inhibiting the Wnt signaling pathway
por: Bu, Xiancong, et al.
Publicado: (2018) -
Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice
por: Wang, Yanjie, et al.
Publicado: (2022) -
Treatment of radiation-induced brain injury with bisdemethoxycurcumin
por: Chang, Yun-Qian, et al.
Publicado: (2022) -
Wnt3a promotes epithelial–mesenchymal transition, migration, and proliferation of lens epithelial cells
por: Bao, Xiu-li, et al.
Publicado: (2012) -
Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer
por: Wang, Biao, et al.
Publicado: (2017)